Bradley-Whitman, M., Timmons, M., Beckett, T., Murphy, M., Lynn, B., & Lovell, M. (2014). Nucleic acid oxidation: an early feature of Alzheimer’s disease. Journal of Neurochemistry, 128(2), 294-304. https://doi.org/10.1111/jnc.12444

Lovell, M., Abner, E., Kryscio, R., Xu, L., Fister, S., & Lynn, B. Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production. Oxidative Medicine and Cellular Longevity, 2015, 787805. https://doi.org/10.1155/2015/787805 (Original work published 2015)

Bradley-Whitman, M., Abner, E., Lynn, B., & Lovell, M. A Novel Plasma Based Biomarker of Alzheimer’s Disease. Journal of Alzheimer’s Disease : JAD, 47(3), 761-71. https://doi.org/10.3233/JAD-150183 (Original work published 2015)

Lovell, M., Lynn, B., Fister, S., Bradley-Whitman, M., Murphy, M., Beckett, T., & Norris, C. (2016). A Novel Small Molecule Modulator of Amyloid Pathology. Journal of Alzheimer’s Disease : JAD, 53(1), 273-87. https://doi.org/10.3233/JAD-151160 (Original work published 2016)

Bradley-Whitman, M., Roberts, K., Abner, E., Scheff, S., Lynn, B., & Lovell, M. A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury. Brain Injury, 32(3), 363-380. https://doi.org/10.1080/02699052.2017.1418907 (Original work published 2018)

Smith, C., Chebrolu, H., Andersen, A., Powell, D., Lovell, M., Xiong, S., & Gold, B. (2010). White matter diffusion alterations in normal women at risk of Alzheimer’s disease. Neurobiology of Aging, 31(7), 1122-31. https://doi.org/10.1016/j.neurobiolaging.2008.08.006

Lovell, M., & Markesbery, W. (2006). Amyloid beta peptide, 4-hydroxynonenal and apoptosis. Current Alzheimer Research, 3(4), 359-64. https://doi.org/10.2174/156720506778249506

Markesbery, W., & Lovell, M. (1969). DNA oxidation in Alzheimer’s disease. Antioxidants & Redox Signaling, 8(11-12), 2039-45. https://doi.org/10.1089/ars.2006.8.2039 (Original work published 1969)

Mehta, S., Watts, G., Adamson, J., Hutton, M., Umberger, G., Xiong, S., … Smith, C. (2007). APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD). Genetics in Medicine : Official Journal of the American College of Medical Genetics, 9(1), 9-13. https://doi.org/10.1097/gim.0b013e31802d830d

Xiong, S., Markesbery, W., Shao, C., & Lovell, M. (2007). Seleno-L-methionine protects against beta-amyloid and iron/hydrogen peroxide-mediated neuron death. Antioxidants & Redox Signaling, 9(4), 457-67. https://doi.org/10.1089/ars.2006.1363